Effect of serum growth differentiation factor-15 and the syntax score on 2-year outcomes in patients with acute coronary syndrome

American Journal of Cardiology

Volumn 117, Issue 10, 2016, Pages 1569-1574

  Dominguez Rodriguez, Alberto ^a,b   Abreu Gonzalez, Pedro ^c   Avanzas, Pablo ^d   Consuegra Sanchez, Luciano ^e  

^a HOSPITAL UNIVERSITARIO DE CANARIAS   (Spain)

^b Facultad de Ciencias de la Salud   (Spain)

^c UNIVERSIDAD DE LA LAGUNA   (Spain)

^d HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^e Hospital Universitario de Santa Lucia   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; GROWTH DIFFERENTIATION FACTOR 15; HIGH SENSITIVITY C REACTIVE PROTEIN; UNCLASSIFIED DRUG; BIOLOGICAL MARKER;

ADULT; AGED; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ANGIOGRAPHY; CORRELATIONAL STUDY; FEMALE; FOLLOW UP; HEART INFARCTION; HOSPITAL READMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; NON ST SEGMENT ELEVATION ACUTE CORONARY SYNDROME; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SYNTAX SCORE; UNSTABLE ANGINA PECTORIS; ACUTE CORONARY SYNDROME; BLOOD; DISEASE COURSE; ELECTROCARDIOGRAPHY; EPIDEMIOLOGY; METABOLISM; MIDDLE AGED; MORTALITY; PROCEDURES; RISK ASSESSMENT; RISK FACTOR; SEVERITY OF ILLNESS INDEX; SPAIN; SURVIVAL RATE; TIME FACTOR; TRENDS;

ACUTE CORONARY SYNDROME; BIOMARKERS; C-REACTIVE PROTEIN; CORONARY ANGIOGRAPHY; DISEASE PROGRESSION; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; GROWTH DIFFERENTIATION FACTOR 15; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SPAIN; SURVIVAL RATE; TIME FACTORS;

EID: 84961266962     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2016.02.031     Document Type: Article

References (29)

1. S.P. Whelton, V. Narla, M.J. Blaha, K. Nasir, R.S. Blumenthal, N.S. Jenny, M.H. Al-Mallah, and E.D. Michos Association between resting heart rate and inflammatory biomarkers (high-sensitivity C-reactive protein, interleukin-6, and fibrinogen) (from the Multi-Ethnic Study of Atherosclerosis) Am J Cardiol 113 2014 644 649
2. W.H. Tang, N. Iqbal, Y. Wu, and S.L. Hazen Usefulness of cardiac biomarker score for risk stratification in stable patients undergoing elective cardiac evaluation across glycemic status Am J Cardiol 111 2013 465 470
3. C. Antoniades, C. Bakogiannis, D. Tousoulis, A.S. Antonopoulos, and C. Stefanadis The CD40/CD40 ligand system: linking inflammation with atherothrombosis J Am Coll Cardiol 54 2009 669 677
4. J.M. Cheng, R.M. Oemrawsingh, H.M. Garcia-Garcia, K.M. Akkerhuis, I. Kardys, S.P. de Boer, J.S. Langstraat, E. Regar, R.J. van Geuns, P.W. Serruys, and E. Boersma Relation of C-reactive protein to coronary plaque characteristics on gray scale, radiofrequency intravascular ultrasound, and cardiovascular outcome in patients with acute coronary syndrome or stable angina pectoris (from the ATHEROREMO-IVUS study) Am J Cardiol 114 2014 1497 1503
5. T. Kempf, M. Eden, J. Strelau, J. Heineke, D. Kotlarz, J. Xu, J.D. Molkentin, H.W. Niessen, H. Drexler, and K.C. Wollert The transforming growth factor-beta superfamily member growth-differentiation factor-15 protects the heart from ischemia/reperfusion injury Circ Res 98 2006 351 360
6. A. Dominguez-Rodriguez, P. Abreu-Gonzalez, I.F. Hernandez-Baldomero, P. Avanzas, and F. Bosa-Ojeda Change in growth differentiation factor 15, but not C-reactive protein, independently predicts major cardiac events in patients with non-ST elevation acute coronary syndrome Mediators Inflamm 2014 2014 929536
7. M.A. Velders, L. Wallentin, R.C. Becker, A.J. van Boven, A. Himmelmann, S. Husted, H.A. Katus, D. Lindholm, J. Morais, A. Siegbahn, R.F. Storey, L. Wernroth, S.K. James PLATO Investigators Biomarkers for risk stratification of patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention: insights from the Platelet Inhibition and Patient Outcomes trial Am Heart J 169 2015 879 889
8. I. Eitel, P. Blase, V. Adams, L. Hildebrand, S. Desch, G. Schuler, and H. Thiele Growth-differentiation factor 15 as predictor of mortality in acute reperfused ST-elevation myocardial infarction: insights from cardiovascular magnetic resonance Heart 97 2011 632 640
9. D.W. Schopfer, I.A. Ku, M. Regan, and M.A. Whooley Growth differentiation factor 15 and cardiovascular events in patients with stable ischemic heart disease (The Heart and Soul Study) Am Heart J 167 2014 186 192
10. M.M. Chan, R. Santhanakrishnan, J.P. Chong, Z. Chen, B.C. Tai, O.W. Liew, T.P. Ng, L.H. Ling, D. Sim, K.T. Leong, P.S. Yeo, H.Y. Ong, F. Jaufeerally, R.C. Wong, P. Chai, A.F. Low, A.M. Richards, and C.S. Lam Growth differentiation factor 15 in heart failure with preserved vs. reduced ejection fraction Eur J Heart Fail 18 2016 81 88
11. A. Dominguez-Rodriguez, P. Abreu-Gonzalez, and P. Avanzas Usefulness of growth differentiation factor-15 levels to predict diabetic cardiomyopathy in asymptomatic patients with type 2 diabetes mellitus Am J Cardiol 114 2014 890 894
12. P.W. Serruys, Y. Onuma, S. Garg, G. Sarno, M. van den Brand, A.P. Kappetein, N. Van Dyck, M. Mack, D. Holmes, T. Feldman, M.C. Morice, A. Colombo, E. Bass, K. Leadley, K.D. Dawkins, G.A. van Es, M.A. Morel, and F.W. Mohr Assessment of the SYNTAX score in the Syntax study EuroIntervention 5 2009 50 56
13. D. Capodanno, P. Capranzano, M.E. Di Salvo, A. Caggegi, D. Tomasello, G. Cincotta, M. Miano, M. Patané, C. Tamburino, S. Tolaro, L. Patané, A.M. Calafiore, and C. Tamburino Usefulness of SYNTAX score to select patients with left main coronary artery disease to be treated with coronary artery bypass graft JACC Cardiovasc Interv 2 2009 731 738
14. S. Garg, G. Sarno, P.W. Serruys, A.E. Rodriguez, L. Bolognese, M. Anselmi, N. De Cesare, S. Colangelo, R. Moreno, S. Gambetti, M. Monti, L. Bristot, M. Bressers, H.M. Garcia-Garcia, G. Parrinello, G. Campo, M. Valgimigli STRATEGY and MULTISTRATEGY Investigators Prediction of 1-year clinical outcomes using the syntax score in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a substudy of the STRATEGY (Single High-Dose Bolus Tirofiban and Sirolimus-Eluting Stent Versus Abciximab and Bare-Metal Stent in Acute Myocardial Infarction) and MULTISTRATEGY (Multicenter Evaluation of Single High-Dose Bolus Tirofiban Versus Abciximab With Sirolimus-Eluting Stent or Bare-Metal Stent in Acute Myocardial Infarction Study) trials JACC Cardiovasc Interv 4 2011 66 75
15. D. Capodanno, M.E. Di Salvo, G. Cincotta, M. Miano, C. Tamburino, and C. Tamburino Usefulness of the SYNTAX score for predicting clinical outcome after percutaneous coronary intervention of unprotected left main coronary artery disease Circ Cardiovasc Interv 2 2009 302 308
16. A. Caixeta, P. Généreux, T. Palmerini, A.J. Lansky, R. Mehran, G.D. Dangas, K. Xu, S.J. Brener, and G.W. Stone Prognostic utility of the SYNTAX score in patients with single versus multivessel disease undergoing percutaneous coronary intervention (from the Acute Catheterization and Urgent Intervention Triage StrategY [ACUITY] trial) Am J Cardiol 113 2014 203 210
17. T. Palmerini, P. Calabrò, F. Piscione, S. De Servi, M. Cattaneo, D. Maffeo, A. Toso, A. Bartorelli, C. Palmieri, M. De Carlo, D. Capodanno, C. Barozzi, L. Tomasi, D. DellaRiva, A. Mariani, N. Taglieri, L.B. Reggiani, R. Bianchi, R. De Rosa, M. Mariani, G. Podda, P. Généreux, G.W. Stone, and D.J. Angiolillo Impact of gene polymorphisms, platelet reactivity, and the SYNTAX score on 1-year clinical outcomes in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention: the GEPRESS study JACC Cardiovasc Interv 7 2014 1117 1127
18. K. Thygesen, J.S. Alpert, A.S. Jaffe, M.L. Simoons, B.R. Chaitman, H.D. White Task Force for the Universal Definition of Myocardial Infarction Third universal definition of myocardial infarction Nat Rev Cardiol 9 2012 620 633
19. A. Dominguez-Rodriguez, P. Abreu-Gonzalez, and J.C. Kaski Inflammatory systemic biomarkers in setting acute coronary syndromes - effects of the diurnal variation Curr Drug Targets 10 2009 1001 1008
20. M.H. Zweig, and G. Campbell Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine Clin Chem 39 1993 561 577
21. M.R. Bootcov, A.R. Bauskin, S.M. Valenzuela, A.G. Moore, M. Bansal, X.Y. He, H.P. Zhang, M. Donnellan, S. Mahler, K. Pryor, B.J. Walsh, R.C. Nicholson, W.D. Fairlie, S.B. Por, J.M. Robbins, and S.N. Breit MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamily Proc Natl Acad Sci U S A 94 1997 11514 11519
22. K.C. Wollert, T. Kempf, B. Lagerqvist, B. Lindahl, S. Olofsson, T. Allhoff, T. Peter, A. Siegbahn, P. Venge, H. Drexler, and L. Wallentin Growth differentiation factor 15 for risk stratification and selection of an invasive treatment strategy in non ST-elevation acute coronary syndrome Circulation 116 2007 1540 1548
23. K.C. Wollert, T. Kempf, T. Peter, S. Olofsson, S. James, N. Johnston, B. Lindahl, R. Horn-Wichmann, G. Brabant, M.L. Simoons, P.W. Armstrong, R.M. Califf, H. Drexler, and L. Wallentin Prognostic value of growth-differentiation factor-15 in patients with non-ST-elevation acute coronary syndrome Circulation 115 2007 962 971
24. A. Ghattas, H.R. Griffiths, A. Devitt, G.Y. Lip, and E. Shantsila Monocytes in coronary artery disease and atherosclerosis: where are we now? J Am Coll Cardiol 62 2013 1541 1551
25. R. Ross Atherosclerosis: an inflammatory disease N Engl J Med 340 1999 115 126
26. W. Koenig, H. Löwel, J. Baumert, and C. Meisinger C-reactive protein modulates risk prediction based on the Framingham Score: implications for future risk assessment: results from a large cohort study in southern Germany Circulation 109 2004 1349 1353
27. M. Cushman, A.M. Arnold, B.M. Psaty, T.A. Manolio, L.H. Kuller, G.L. Burke, J.F. Polak, and R.P. Tracy C-reactive protein and the 10-year incidence of coronary heart disease in older men and women: the cardiovascular health study Circulation 112 2005 25 31
28. J.K. Pai, T. Pischon, J. Ma, J.E. Manson, S.E. Hankinson, K. Joshipura, G.C. Curhan, N. Rifai, C.C. Cannuscio, M.J. Stampfer, and E.B. Rimm Inflammatory markers and the risk of coronary heart disease in men and women N Engl J Med 351 2004 2599 2610
29. M. Miller, M. Zhan, and S. Havas High attributable risk of elevated C-reactive protein level to conventional coronary heart disease risk factors: the Third National Health and Nutrition Examination Survey Arch Intern Med 165 2005 2063 2068